Chronic lymphocytic leukemia (CLL) is a B-cell neoplasm characterized by typical CD19, CD5, CD20, and CD23 immunophenotypes, as well as kappa or lambda light chain restrictions [1,2]. This evidence concerns the gene FCER2 and B-cell chronic lymphocytic leukemia.